Sudan Journal of Medical Sciences Volume 16, Issue no. 1, DOI 10.18502/sjms.v16i1.8935 Production and Hosting by Knowledge E Research Article Determination of Normal and Variant Hemoglobin using Capillary Electrophoresis among Voluntary Blood Donors in North Central Nigeria: Implications on Blood Transfusion Services Idayat Adenike Durotoye1, Adekunle Ganiyu Salaudeen2, Emmanuel Oladipo Sanni3, Abiola Samuel Babatunde1, Adekunle Kabir Durowade4, Hannah Oluwayemisi Olawumi1, Tanimola Makanjuola Akande2, and Omotosho Ibrahim Musa2 1FMCPath. Department of Haematology, University of Ilorin, Nigeria 2Dr Adekunle Ganiyu Salaudeen FWCP. Department of Epidemiology and Community Health, University of Ilorin, Nigeria 3Dr Emmanuel Oladipo Sanni, FMCPath. Department of Haematology, Faculty of Basic Clinical Sciences, Nile University of Nigeria, Nigeria 4Dr Adekunle Kabir Durowade, FMCPH. Department of Community Medicine, Afe-Babalola University, Ado Ekiti, Nigeria ORCID: Idayat Adenike Durotoye: http://orcid.org/0000-0001-5274-1829 Abstract Background: Voluntary non-remunerated blood donation is a strategy adopted by World Health Organization aimed at ensuring safety and adequacy of blood supply. Sub-Saharan Africa has a high prevalence of hemoglobin disorders and therefore needs to adopt stringent measures in donor selection to ensure safety for the recipient of blood transfusion. This study aimed to analyze normal and variant hemoglobin among voluntary blood donors. Methods: In this descriptive cross-sectional study, 100 prospective blood donors including 55 (55%) males and 45 (45%) females, aged 18–34 years were recruited. Capillary electrophoresis using the Minicap system was used for determining the hemoglobin variants in alkaline buffer (PH 9.4). Data analysis was done using SPSS version 20 and p-value < 0.05 was considered as the level of significance Results: The mean age of the participants was 22.23 ± 3.3 SD years. The proportion of participants with genotype AA was 67 (67%), those with AS were 17 (22 %), while those with AC were 11 (11 %). While Hb A ≥ 90% was noted in 67 (67%) blood donors, Hb S was seen in 22 (22%) and Hb A2 > 3.5% in 57 (57%). Hb F > 2% was observed in 3% of the studied participants Conclusion: Variant hemoglobin is common among blood donors and this should be taken into consideration whenever blood is being crossmatched for recipients of blood transfusion. Data from this study will be useful in raising awareness and genetic counseling. Keywords: prevalence, hemoglobin variants, capillary electrophoresis How to cite this article: Idayat Adenike Durotoye, Adekunle Ganiyu Salaudeen, Emmanuel Oladipo Sanni, Abiola Samuel Babatunde, Adekunle Kabir Durowade, Hannah Oluwayemisi Olawumi, Tanimola Makanjuola Akande, and Omotosho Ibrahim Musa (2021) “Determination of Normal and Variant Hemoglobin using Capillary Electrophoresis among Voluntary Blood Donors in North Central Nigeria: Implications on Blood Transfusion Services,” Sudan Journal of Medical Sciences, vol. 16, Issue no. 1, pages 33–42. DOI 10.18502/sjms.v16i1.8935 Page 33 Corresponding Author: Idayat Adenike Durotoye; Department of Haematology, Faculty of Basic Medical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria. email: idayat2007@yahoo.co.uk Received 2 January 2021 Accepted 16 March 2021 Published 31 March 2021 Production and Hosting by Knowledge E Idayat Adenike Durotoye et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. Editor-in-Chief: Prof. Mohammad A. M. Ibnouf http://www.knowledgee.com mailto:idayat2007@yahoo.co.uk https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/ Sudan Journal of Medical Sciences Idayat Adenike Durotoye et al 1. Introduction Structural abnormalities affecting the polypeptide chain of the globin molecule are disorders inherited genetically as occurs in hemoglobin (Hb) C, Hb S, Hb E. Hemoglobin disorder is one of the most common inherited genetic disorder worldwide and accounts for about 7% of the world population (approximately 269 million people) said to be carriers [1, 2]. The emotional and economic burden of managing hemoglobin disorders is quite enormous especially in Africa with limited resources. The sub-Saharan part of Africa has a prevalence of 10–45% for carriers of sickle cell [3, 4] and about 20–30% of the Nigerian population is reported to be carriers of the mutant S gene [5, 6]. A previous study done among people living in the south western part of Nigeria reported the prevalence of Hb AC (Hb C trait) to be 6% [7]. About 270 million people all over the world are carriers of abnormal hemoglobin [8]. Hemoglobin electrophoretic analysis of hemoglobin variants in previous studies in Nigeria and other part of sub-Saharan Africa was largely carried out with the use of cellulose acetate method at alkaline pH [7, 9]. Analyzing Hb with the use of capillary electrophoresis has been identified with increased accuracy. Of note, for the numerical and qualitative analysis of hemoglobin, superlative similarity between use of capillary electrophoresis and high-performance cation-exchange chromatography (HPLC) has been established and reported in several previous studies [10–12]. The task of ensuring safe, continuous, and adequate supply of blood as instructed by World Health Organisation (WHO) will remain sacrosanct. Blood transfusion safety entails blood collection from voluntary, non-remunerated, risk-free donors with strict adherence to procedures for selecting donors [13]. The suitability of blood donated by donors with sickle cell trait has limitations for use in some clinical situations, although present blood donation criteria allow them to donate blood [13, 14]. In neonatal exchange transfusion as well as intrauterine transfusion, donated blood from sickle cell carriers may not be appropriate due to possible worsening of hypoxia especially when this blood has been stored for couples of days. Transfusing patients with sickle cell anemia who had acute chest syndrome and those with stroke who are on chronic transfusion with blood donated by Hb S carrier may worsen patient’s outcome since such blood are not tagged or separated from other blood units [15]. Blood transfusion in patient with sickle cell anemia who had stroke is intended to lower the proportion of Hb S to value <30%, thus blood donated by SCT will not be appropriate for this category of patients [15, 16]. DOI 10.18502/sjms.v16i1.8935 Page 34 Sudan Journal of Medical Sciences Idayat Adenike Durotoye et al This study intends to determine hemoglobin variants among blood donors using capillary electrophoresis method. 2. Materials and Methods 2.1. Study design This study is a descriptive cross-sectional study. It assesses the Hb variants among voluntary blood donors. 2.2. Study participants The recruited participants included 100 prospective blood donors who met the required criteria for blood donor selection. The participants were male and female students of Kwara State Polytechnic, Ilorin who were aged between 18 and 34 years. Only those that granted consent were included in the study. 2.3. Materials and tools Materials and tools used included the H6500CAP analyser, tri-potassium ethylene diamine tetra-acetic acid (K3EDTA) tubes, reagents cups and filters, centrifuge, and capiclean. The prepared solutions and reagents used included wash solution, hemolyzing reagent, the kit containing use stock reagents, distilled water, B2 buffer solution, A2 control, and AFSC control. 2.4. Sampling method Convenient sampling method was adopted for the recruitment of blood donors. The studied participants were enrolled via a non-probability method of sampling. They were recruited based on their readiness to donate blood. 2.5. Sample collection Four milliliters of blood were collected via venipuncture from the ante-cubital vein and was subsequently put into labelled K3EDTA tubes. The collected samples were kept DOI 10.18502/sjms.v16i1.8935 Page 35 Sudan Journal of Medical Sciences Idayat Adenike Durotoye et al at 2–8°C. Sample analysis was carried out in the laboratory within a period of 24 hr of blood collection. 2.6. Principle and procedure In capillary electrophoresis, normal hemoglobin was separated via electrophoretic mobility of the charged molecules into hemoglobin A, A2, and F. The common hemoglobin variants including S, C, E, or D were detected via electrophoresis in alkaline buffer at pH 9.4. The surface charge of the hemoglobin variants are different and thus their electrophoretic mobility in free solution is also different. The electro osmotic flow and pH of the electrolytes also determine the separation of the charged molecules. Capillary electrophoresis using the Minicap system was used to analyze the variants of hemoglobin. The analyzer directly detected the Hb variants S, C, E, and D while the normal Hb were separated into A, F, and A2. The Minicap system with its silica capillaries works efficiently in parallel allowing two concurrent analysis of Hb. At 415-nm wavelength of the absorbance, specific and direct detection of the separated Hb were done. The procedure was carried out according to the company’s manual. 4 ml of the collected donor blood sample in EDTA bottle was put in a plastic tube (labeled). With the use of a centrifuge, the blood in the plastic tube was then spinned at a rated of 5000 per minute for a total of 7 mins. With a micropipette, 200 hundred microliters of packed red cell were subsequently introduced into a nesting cup. The open analyzer (H6500CAP) was started and a 10- ml solution of the hemolyzing reagent was put inside the tube placed in position 27. The door was closed, and the OK button was clicked. The analyzer then requested for the control in position 28. 200-µl of the control reagent was subsequently placed in a nesting cup and placed into the labeled hemoglobin A2 control tube at position number 28. The door was then closed, and the OK button was clicked. An indicator appeared requesting to input the lot # and analysis was done after selecting 1 run button. The assembled test samples were then put inside the rotating wheel (carousel) of the analyzer from locations numbered 1–26 and the door was closed. The instrument was now left to run the samples. Analysis of the results was done as stated in the company’s manual. DOI 10.18502/sjms.v16i1.8935 Page 36 Sudan Journal of Medical Sciences Idayat Adenike Durotoye et al 2.7. Data analysis and ethical consideration Relevant information was collected using structured questionnaires and data generated from the study was subsequently analyzed using SPSS version 20. The proportion and percentages of hemoglobin variant of blood donors were determined. The means and standard deviation of the age, gender, and each of the normal hemoglobin analyzed were established using the independent t-test while comparison of proportion was done using Chi-square. Test of significance was put at values of p < 0.05. 3. Results In this study of 100 donors, 55 (55%) were males and 45 (45 %) females. The mean age of the participants was 22.23 ± 3.3 SD years. Fifty-seven (57%) participants were aged 20–24 years and were found to have the highest donation (Table 1). The proportion of participants with phenotype AA was 67 (67%), those with AS was 17 (22 %), while those with AC was 11 (11 %). Among participants with phenotype AA, the proportions of males was 38 (38 %) while that of females was 29 (29%). For participants with phenotype AS, the proportions of males was 10 (10%) and that of females 12 (12%). Seven (7%) and four (4%) females were of phenotype AC (Table 2). Hb A ≥ 90% was noted in 67 (67%) blood donors, Hb S was seen in 22 (22%), while Hb A2 > 3.5% was seen in 57 (57%). Hb F > 2% was observed in 3% of the studied participants (Table 3). TABLE 1: Gender and age group distribution among voluntary blood donors. Variables Frequency Percentage (%) Gender Male 55 55 Female 45 45 Total 100 100 Age group (yrs) 15–19 22 22 20–24 57 57 25–29 19 19 30–34 2 2 Total 100 100 DOI 10.18502/sjms.v16i1.8935 Page 37 Sudan Journal of Medical Sciences Idayat Adenike Durotoye et al TABLE 2: Prevalence of hemoglobin phenotypes among voluntary blood donors. Hb Variants Gender Proportion Percentage Male Female AA 38 (38%) 29 (29%) 67 67% AC 7 (7%) 4 (4%) 11 11% AS 10 (10%) 12 (12%) 22 22% Total 55 (55%) 45 (45%) TABLE 3: Proportion of donors with normal and specific hemoglobin variants. Hemoglobin Frequency Percentage (%) Hb A 100 100.0 Hb A ≥≥≥ 90.0% Yes 67 67.0 No 33 33.0 Hb A2 100 100.0 Hb A2 >>> 3.5% Yes 53 53.0 No 47 47.0 Hb S 22 22.0 Hb F 16 16.0 Hb F >>> 2.0% (n = 16) Yes 3 18.8 No 13 81.3 Hb F with Hb S 3 3.0 Hb F >>> 2.0% and Hb S (n = 3) Yes 1 33.3 No 2 66.7 Hb C 11 2 Hb A2 >>> 3.9% and Hb F >>> 1% 2 11 On the hemoglobin variants among the donors, about a quarter had HbS. Only 3% had both HbS and HbF. 4. Discussion Blood transfusion is a clinical procedure aimed at correcting anemia, replacing losses from hemorrhages, supporting patients on chemotherapy, and so on. It is thus a lifesav- ing procedure. Careful and selective processes are undertaken by blood bank service providers to ensure that donated blood is safe for the recipients of this blood. Safe blood donation practice must be given very important consideration to ensure availability of safe blood without risk to the recipient. Despite stringent measures adopted in blood donor selection criteria, quite a number of blood donors who did not know their carrier DOI 10.18502/sjms.v16i1.8935 Page 38 Sudan Journal of Medical Sciences Idayat Adenike Durotoye et al status still find their way into blood donor population and this poses a risk to some category of blood transfusion recipients. Our study reported a prevalence of HbAA to be 67%, HbAS was found to be 22%, while Hb AC was 11%. These findings were consistent with the results of previous works by Garba et al. and Omisakin et al., in which the prevalence rates for Hb AA were reported as 66.9% and 72.4%, respectively [17, 18]. The frequency of Hb AA in our study falls within the normal range of 55–75%, earlier reported among Blacks [19]. The prevalence of Hb AS in our study was 22% and is consistent with the results of Akhigbe et al. who reported 22.19% as prevalence of Hb AS in blood donors among students and Zaccheaus et al. with a finding of 19.68% [20, 21]. Omisakin et al. reported 26.1% for Hb S [18]. High prevalence rate of SCT was noted in children of African descent with up to 10-40% being carriers of the S gene, as reported by WHO in 2006 [17]. The prevalence of carriers of mutant S gene among blood donors as revealed in our study is similar to findings from other parts of Nigeria [17]. Thus, the prevalence rate of Hb S trait is high in Nigeria. The prevalence of Hb C trait in our study was 11%, which was higher than the prevalence of 6% reported in a previous study [7]. Further studies with a larger cohort will be needed to determine the prevalence rate of Hb C trait in our environment. Our study showed Hb A2 > 3.5% in 57 (57%) blood donors which raises the suspicion of a possibility of β-Thalassemia among blood donors in our environment. 5. Conclusion Although blood donors with Hb S trait are allowed to donate their blood if they satisfy the donor selection criteria and screening test for TTIs, the use of blood containing Hb S trait is subject to limitations. The prevalence of Hb S trait is high in Nigeria. Blood banking service providers must ensure screening of donated blood for hemoglobin variants determination before crossmatching blood for recipients who have sickle cell crisis or stroke whenever blood transfusion is indicated. Findings in research studies on Hb S carriers in blood donors can be used for raising awareness and genetic counseling since most voluntary blood donors fall within premarital age group. Thus, blood donation can help prospective blood donors to know their carrier status early and can help them make informed future decisions. Acknowledgement The authors want to appreciate all voluntary blood donors that participated in this study. DOI 10.18502/sjms.v16i1.8935 Page 39 Sudan Journal of Medical Sciences Idayat Adenike Durotoye et al Ethical considerations Ethical approval from the Ethical Committee of the University of Ilorin was obtained prior to the study. Written informed consent was also obtained and participation was voluntary. Competing interests None declared. Availability of data and material The study materials are available with the author upon request. Funding The current research was supported by TETFUND National Research Fund. References [1] World Health Organisation. (2008). Management of haemoglobin disorders. In: Proceedings of the Report of Joint WHO-TIF Meeting, Nicosia, Cyprus. [2] Weatherall, D. J. and Clegg, J. B. (2001). Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization, vol. 79, no. 8, pp. 704–712. [3] WHO Regional office for Africa. Sickle Cell Disease Prevention and Control, 2013. Retrieved from: http://www.afro.who.int/en/nigeria/nigeria-publications/1775- sicklecelldisease.html [4] Serjeant, G. R. and Serjeant B. E. (2001). The epidemiology of sickle cell disorder: a challenge for Africa. Archives of Ibadan Medicine, vol. 2, no. 2, pp. 46–52. [5] Fleming, A. F., Storey, J., Molineaux, L., et al. (1979). Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Annals of Tropical Medicine and Parasitology, vol. 73, no. 2, pp. 161–172. [6] Uzoegwu P. N. and Onwurah, A. E. (2003). Prevalence of haemoglobinopathy and malaria diseases in the population of old Aguata Division, Anambra State, Nigeria. DOI 10.18502/sjms.v16i1.8935 Page 40 http://www.afro.who.int/en/nigeria/nigeria-publications/1775-sickle cell disease.html http://www.afro.who.int/en/nigeria/nigeria-publications/1775-sickle cell disease.html Sudan Journal of Medical Sciences Idayat Adenike Durotoye et al Biokemistri, vol. 15, no. 2, pp. 57–66. [7] Akinyanju, O. O. (1989). A profile of sickle cell disease in Nigeria. Annals of the New York Academy of Sciences, vol. 565, no. 1, pp. 126–136. Retrieved from: https: //doi.org/10.1111/j.1749-6632.1989.tb24159.x [8] De Sanctis, V., Kattamis, C., Canatan, D., et al. (2017). β-Thalassemia distribution in the old world: an ancient disease seen from a historical standpoint. Mediterranean Journal of Hematology and Infectious Diseases, vol. 9, no. 1, p. e2017018. [9] Antwi-Baffour, S., Asare, R. O., Adjei, J. K., et al. (2015). Prevalence of hemoglobin S trait among blood donors: a cross-sectional study. BMC Research Notes, vol. 8, p. 583. [10] Cotton, F., Lin, C., Fontaine, B., et al. 1999 (). Evaluation of a Capillary electrophoresis method for routine determination of hemoglobins A2 and F. Clinical Chemistry, vol. 45, no. 2, pp. 237–243. [11] Mario, N., Baudin, B., Aussel, C., et al. (1997). Capillary isoelectric focusing and high-performance cation-exchange chromatography compared for qualitative and quantitative analysis of hemoglobin variants. Clinical Chemistry, vol. 43, no 11, pp. 2137–2142. [12] Delft van, P., Lenters, E., Bakker-Verweij, M., et al. (2009). Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in Multi-ethnic populations. International Journal of Laboratory Hematology, vol. 31, no. 5, pp. 484–495 [13] World Health Organization, Regional Office for Africa. (2001). Blood Safety: A Strategy for the African Region. Retrieved from: https://apps.who.int/iris/handle/ 10665/95734 [14] World Health Organisation. (2012). Guidelines on Assessing Donor Suitability for Blood Donation. Retrieved from: https://apps.who.int/iris/handle/10665/76724 [15] Davis, B. A., Allard, S., Qureshi, A., et al. (2017). Guidelines on red cell transfusion in sickle cell disease: principles and laboratory aspects. British Journal of Haematology, vol. 176, no. 2, pp. 179–191. [16] Howard, J. (2016). Sickle cell disease: when and how to transfuse. Hematology – The American Society of Hematology Education Program, vol. 16, no. 1, pp. 625–631. [17] Garba, N., Danladi, S. B., Abubakar, H. B., et al. (2016). Distribution of haemoglobin variants, ABO and Rh blood groups in blood donors attending Aminu Kano Teaching Hospital. Clinical Medicine Journal, vol. 2, no. 2, pp. 20–24. [18] Omisakin, C. T., Esan, A. J., Ogunleye, A. A., et al. (2014). Glucose-6-phosphate dehydrogenase (G6PD) deficiency and sickle cell trait among blood donors in Nigeria. American Journal of Public Health, vol. 2, no. 2, pp. 51–55. DOI 10.18502/sjms.v16i1.8935 Page 41 https://doi.org/10.1111/j.1749-6632.1989.tb24159.x https://doi.org/10.1111/j.1749-6632.1989.tb24159.x https://apps.who.int/iris/handle/10665/95734 https://apps.who.int/iris/handle/10665/95734 https://apps.who.int/iris/handle/10665/76724 Sudan Journal of Medical Sciences Idayat Adenike Durotoye et al [19] Erhabor, O., Adias, T. C., Jeremiah, Z. A., et al. (2010). Abnormal haemoglobin variants, ABO and Rh blood group distribution among students in the Niger Delta of Nigeria. Pathology and Laboratory Medicine International, vol. 2010, no. 2, pp. 41–46. [20] Akhigbe, R. E., Ige, S. F., Afolabi, A. O., et al. (2009). Prevalence of haemoglobin variants, ABO and rhesus blood group in Ladoke Akintola University of Technology, Ogbomoso, Nigeria. Trends in Medical Research, vol. 4, no. 2, pp. 24–29. [21] Zaccheaus, A. J. (2006). Abnormal haemoglobin variants, ABO and Rh blood groups among students of African descent in Port Harcourt, Nigeria. Journal of African Health Sciences, vol. 6, no. 3, pp. 177–181. DOI 10.18502/sjms.v16i1.8935 Page 42 Introduction Materials and Methods Study design Study participants Materials and tools Sampling method Sample collection Principle and procedure Data analysis and ethical consideration Results Discussion Conclusion Acknowledgement Ethical considerations Competing interests Availability of data and material Funding References